Income Statement Rorze Corporation

Equities

6323

JP3982200002

Semiconductor Equipment & Testing

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-09-11 am EDT			5-day change	1st Jan Change
1,778.00 ^JPY	-1.06%		-18.25%	+18.06%

Jul. 11	Rorze's Attributable Profit Surges 146.7% in Fiscal Q1	MT
Jun. 24	Nanoverse Technologies, Ltd. announced that it expects to receive $70 million in funding from Rorze Corporation	CI

e0f3bd934.CC08sbdQrZFwhFWHfGl8I7kfZVqViNyL1rUF0-C2cN4.MRVo248779Qh6wzYDydEYNNXU2_4vrj-gNla4YXTG6xXaW_C8BnaxRP2bQ

Published financial data: RORZE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: February	2020	2021	2022	2023	2024
Revenues	37.1B	50.8B	67B	94.52B	93.25B
Total Revenues	37.1B	50.8B	67B	94.52B	93.25B
Cost of Goods Sold, Total	23.82B	36.08B	44.36B	59.71B	57.99B
Gross Profit	13.28B	14.72B	22.64B	34.81B	35.26B
Selling General & Admin Expenses, Total	4.65B	4.51B	5.28B	6.71B	9.33B
Provision for Bad Debts	87M	-61M	-4M	-42M	-1M
R&D Expenses	437M	418M	871M	911M	1.02B
Depreciation & Amortization - (IS)	154M	200M	217M	277M	298M
Other Operating Expenses	207M	339M	461M	535M	475M
Other Operating Expenses, Total	5.54B	5.41B	6.83B	8.39B	11.12B
Operating Income	7.74B	9.31B	15.81B	26.42B	24.14B
Interest Expense, Total	-33M	-44M	-38M	-49M	-70M
Interest And Investment Income	34M	12M	19M	27M	148M
Net Interest Expenses	1M	-32M	-19M	-22M	78M
Currency Exchange Gains (Loss)	-273M	-1.13B	2.18B	3.95B	2.72B
Other Non Operating Income (Expenses)	88M	131M	57M	287M	265M
EBT, Excl. Unusual Items	7.56B	8.29B	18.02B	30.63B	27.2B
Gain (Loss) On Sale Of Investments	-	447M	-68M	-	-
Gain (Loss) On Sale Of Assets	57M	9M	881M	14M	2M
Asset Writedown	-114M	200M	-351M	-294M	-135M
Other Unusual Items	-	0	-1M	-	-1M
EBT, Incl. Unusual Items	7.5B	8.94B	18.48B	30.35B	27.06B
Income Tax Expense	1.99B	2.02B	4.66B	7.65B	6.98B
Earnings From Continuing Operations	5.51B	6.92B	13.82B	22.7B	20.09B
Net Income to Company	5.51B	6.92B	13.82B	22.7B	20.09B
Minority Interest	-43M	-452M	-999M	-1.31B	-512M
Net Income - (IS)	5.47B	6.47B	12.82B	21.38B	19.58B
Net Income to Common Incl Extra Items	5.47B	6.47B	12.82B	21.38B	19.58B
Net Income to Common Excl. Extra Items	5.47B	6.47B	12.82B	21.38B	19.58B
Per Share Items
Net EPS - Basic	31.65	37.44	74.21	123.74	111.11
Basic EPS - Continuing Operations	31.65	37.44	74.21	123.74	111.11
Basic Weighted Average Shares Outstanding	173M	173M	173M	173M	176M
Net EPS - Diluted	31.62	37.38	74.07	123.51	110.91
Diluted EPS - Continuing Operations	31.62	37.38	74.07	123.51	110.91
Diluted Weighted Average Shares Outstanding	173M	173M	173M	173M	177M
Normalized Basic EPS	27.09	27.36	59.4	103.18	93.58
Normalized Diluted EPS	27.06	27.31	59.29	102.99	93.4
Dividend Per Share	3	-	6.5	13.5	13.5
Payout Ratio	7.9	8.01	4.04	5.25	11.91
Supplemental Items
EBITDA	8.7B	10.6B	17.33B	28.4B	26.94B
EBITA	7.74B	9.31B	15.81B	26.42B	24.4B
EBIT	7.74B	9.31B	15.81B	26.42B	24.14B
Effective Tax Rate - (Ratio)	26.52	22.6	25.22	25.22	25.78
Normalized Net Income	4.68B	4.73B	10.27B	17.83B	16.49B
Non-Cash Pension Expense	202M	178M	94.38M	17M	227M
Supplemental Operating Expense Items
General and Administrative Expenses	254M	254M	339M	401M	469M
Research And Development Expense From Footnotes	437M	418M	871M	911M	1.02B

Fiscal Period: February	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	12.84B	16.82B	23.63B	28.29B	37.95B
Total Cash And Short Term Investments	12.84B	16.82B	23.63B	28.29B	37.95B
Accounts Receivable, Total	11.3B	11.29B	18.86B	26.71B	26.45B
Total Receivables	11.3B	11.29B	18.86B	26.71B	26.45B
Inventory	11.64B	11.12B	22.42B	42.83B	53.28B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	523M	716M	1.54B	2.15B	2.46B
Total Current Assets	36.3B	39.94B	66.46B	99.99B	120B
Net Property Plant And Equipment	16.41B	16.66B	17.48B	22.1B	22.62B
Long-term Investments	641M	1.16B	1.69B	2.45B	4.45B
Goodwill	-	-	-	-	2.32B
Other Intangibles, Total	569M	543M	614M	643M	2.9B
Loans Receivable Long-Term	-	274M	274M	5M	1.74B
Deferred Tax Assets Long-Term	859M	955M	1.77B	1.29B	1.96B
Other Long-Term Assets, Total	2M	2M	1M	2M	1M
Total Assets	54.78B	59.53B	88.29B	126B	156B
Liabilities
Accounts Payable, Total	3.05B	2.62B	6.85B	7.35B	6.39B
Accrued Expenses, Total	537M	748M	925M	1.09B	1.36B
Short-term Borrowings	9.88B	11.47B	11.92B	14.94B	16.34B
Current Portion of Leases	2M	2M	1M	-	3M
Current Income Taxes Payable	1.32B	1.32B	4.44B	4.36B	4.71B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	2.92B	2.69B	4.35B	5.31B	7.62B
Total Current Liabilities	17.72B	18.85B	28.49B	33.04B	36.43B
Long-Term Debt	7.8B	5.3B	8.96B	17.89B	18.17B
Long-Term Leases	3M	1M	-	-	7M
Pension & Other Post Retirement Benefits	451M	512M	406M	373M	505M
Deferred Tax Liability Non Current	-	-	-	105M	997M
Other Non Current Liabilities	230M	261M	211M	280M	482M
Total Liabilities	26.21B	24.93B	38.07B	51.69B	56.59B
Common Stock, Total	982M	982M	982M	982M	982M
Additional Paid In Capital	1.47B	1.47B	1.47B	1.47B	5.23B
Retained Earnings	23.25B	29.2B	41.51B	61.22B	78.46B
Treasury Stock	-53M	-54M	-54M	-55M	-3M
Comprehensive Income and Other	-304M	-686M	1.53B	4.69B	7.62B
Total Common Equity	25.34B	30.91B	45.43B	68.31B	92.3B
Minority Interest	3.23B	3.69B	4.79B	6.49B	7.25B
Total Equity	28.57B	34.6B	50.22B	74.79B	99.55B
Total Liabilities And Equity	54.78B	59.53B	88.29B	126B	156B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	173M	173M	173M	176M	176M
ECS Total Common Shares Outstanding	173M	-	173M	173M	176M
Book Value / Share	146.65	178.87	262.9	395.26	523.81
Tangible Book Value	24.78B	30.37B	44.82B	67.66B	87.08B
Tangible Book Value Per Share	143.36	175.73	259.35	391.54	494.18
Total Debt	17.69B	16.77B	20.88B	32.82B	34.51B
Net Debt	4.85B	-57M	-2.75B	4.53B	-3.44B
Debt Equivalent of Unfunded Proj. Benefit Obligation	206M	246M	116M	-122M	-162M
Minority Interest, Total (Incl. Fin. Div)	3.23B	3.69B	4.79B	6.49B	7.25B
Inventories - Raw Materials, Total	7.7B	6.31B	14.66B	25.99B	33.87B
Inventories - Work In Process, Total	3.53B	3.68B	6.02B	14.07B	12.54B
Inventories - Finished Goods, Total	412M	1.12B	1.74B	2.78B	6.87B
Inventories - Others	2M	2M	1M	-	-
Full Time Employees	1.9K	2.47K	3.67K	4.37K	4K
Accumulated Allowance for Doubtful Accounts (Supple)	114M	54M	53M	12M	10M
Order Backlog	15.55B	18.45B	51.82B	56.88B	63.97B

Fiscal Period: February	2020	2021	2022	2023	2024
Net Income	7.5B	8.94B	18.48B	30.35B	27.07B
Depreciation & Amortization - CF	960M	1.29B	1.52B	1.98B	2.55B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	257M
Depreciation & Amortization, Total	960M	1.29B	1.52B	1.98B	2.8B
(Gain) Loss From Sale Of Asset	13M	-8M	-734M	-9M	10M
(Gain) Loss on Sale of Investments - (CF)	-	-370M	68M	-	-
Other Operating Activities, Total	-2.21B	-2.05B	-2.38B	-6.99B	-7.93B
Change In Accounts Receivable	-3.62B	111M	-7.1B	-8.6B	1.23B
Change In Inventories	2.08B	-4M	-10.48B	-16.8B	-6.1B
Change In Accounts Payable	512M	-402M	4.04B	-186M	-1.6B
Change in Other Net Operating Assets	1.43B	643M	-403M	-1.66B	61M
Cash from Operations	6.66B	8.16B	3.02B	-1.92B	15.54B
Capital Expenditure	-5.71B	-2.32B	-2.04B	-4.51B	-1.22B
Sale of Property, Plant, and Equipment	147M	141M	1.99B	29M	4M
Cash Acquisitions	-	-	-	-	-1.78B
Sale (Purchase) of Intangible assets	-372M	-126M	-76M	-62M	-84M
Investment in Marketable and Equity Securities, Total	3M	-21M	-482M	-21M	-1.56B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-274M	-272M	-7M	-1.19B
Other Investing Activities, Total	228M	-58M	-33M	-580M	-75M
Cash from Investing	-5.7B	-2.66B	-916M	-5.15B	-5.91B
Short Term Debt Issued, Total	82M	-	1B	350M	31M
Long-Term Debt Issued, Total	3.24B	3B	9.1B	18.2B	11B
Total Debt Issued	3.32B	3B	10.1B	18.55B	11.03B
Short Term Debt Repaid, Total	-	-443M	-	-	-
Long-Term Debt Repaid, Total	-2.45B	-3.48B	-6B	-6.66B	-9.44B
Total Debt Repaid	-2.45B	-3.93B	-6B	-6.66B	-9.44B
Issuance of Common Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-432M	-518M	-518M	-1.12B	-2.33B
Common & Preferred Stock Dividends Paid	-432M	-518M	-518M	-1.12B	-2.33B
Other Financing Activities, Total	-1M	-4M	-3M	-21M	-47M
Cash from Financing	434M	-1.45B	3.58B	10.74B	-792M
Foreign Exchange Rate Adjustments	-90M	-62M	1.13B	989M	815M
Miscellaneous Cash Flow Adjustments	-1M	-1M	-	-	-1M
Net Change in Cash	1.3B	3.99B	6.81B	4.66B	9.66B
Supplemental Items
Cash Interest Paid	31M	45M	40M	50M	70M
Cash Income Tax Paid (Refund)	2.21B	2.04B	2.37B	6.99B	7.92B
Levered Free Cash Flow	1B	4.53B	-1.26B	-13.44B	8.03B
Unlevered Free Cash Flow	1.02B	4.55B	-1.24B	-13.41B	8.08B
Change In Net Working Capital	-1.3B	111M	10.52B	27.33B	8.51B
Net Debt Issued / Repaid	867M	-927M	4.1B	11.89B	1.59B

Fiscal Period: February	2020	2021	2022	2023	2024
Profitability
Return on Assets	9.47	10.19	13.37	15.38	10.68
Return on Total Capital	11.12	11.92	16.14	18.48	12.49
Return On Equity %	21	21.91	32.59	36.31	23.04
Return on Common Equity	23.81	23	33.59	37.6	24.38
Margin Analysis
Gross Profit Margin %	35.8	28.97	33.79	36.82	37.81
SG&A Margin	12.54	8.88	7.89	7.1	10
EBITDA Margin %	23.46	20.87	25.87	30.04	28.89
EBITA Margin %	20.87	18.33	23.6	27.95	26.16
EBIT Margin %	20.87	18.33	23.6	27.95	25.89
Income From Continuing Operations Margin %	14.86	13.63	20.63	24.01	21.54
Net Income Margin %	14.74	12.74	19.14	22.62	20.99
Net Avail. For Common Margin %	14.74	12.74	19.14	22.62	20.99
Normalized Net Income Margin	12.62	9.31	15.32	18.87	17.68
Levered Free Cash Flow Margin	2.7	8.91	-1.88	-14.22	8.61
Unlevered Free Cash Flow Margin	2.76	8.96	-1.85	-14.19	8.66
Asset Turnover
Asset Turnover	0.73	0.89	0.91	0.88	0.66
Fixed Assets Turnover	2.65	3.07	3.93	4.78	4.17
Receivables Turnover (Average Receivables)	3.88	4.5	4.44	4.15	3.51
Inventory Turnover (Average Inventory)	1.85	3.17	2.65	1.83	1.21
Short Term Liquidity
Current Ratio	2.05	2.12	2.33	3.03	3.3
Quick Ratio	1.36	1.49	1.49	1.66	1.77
Operating Cash Flow to Current Liabilities	0.38	0.43	0.11	-0.06	0.43
Days Sales Outstanding (Average Receivables)	94.21	81.12	82.12	87.99	104.32
Days Outstanding Inventory (Average Inventory)	197.49	115.08	137.97	199.45	303.32
Average Days Payable Outstanding	48.09	29.11	31.04	32.34	36.74
Cash Conversion Cycle (Average Days)	243.61	167.09	189.05	255.1	370.9
Long Term Solvency
Total Debt/Equity	61.92	48.46	41.59	43.89	34.67
Total Debt / Total Capital	38.24	32.64	29.37	30.5	25.74
LT Debt/Equity	27.33	15.31	17.84	23.92	18.26
Long-Term Debt / Total Capital	16.88	10.31	12.6	16.62	13.56
Total Liabilities / Total Assets	47.84	41.87	43.12	40.87	36.24
EBIT / Interest Expense	234.67	211.68	416.05	539.14	344.84
EBITDA / Interest Expense	263.76	241	456.08	579.55	384.9
(EBITDA - Capex) / Interest Expense	90.76	188.27	402.39	487.51	367.5
Total Debt / EBITDA	2.03	1.58	1.21	1.16	1.28
Net Debt / EBITDA	0.56	-0.01	-0.16	0.16	-0.13
Total Debt / (EBITDA - Capex)	5.91	2.02	1.37	1.37	1.34